| For: | Hegazy MA, Ahmed SM, Sultan SM, Afifi OF, Mohamed MA, Azab AE, Hassanen MA, Zaben RK. Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes. World J Hepatol 2025; 17(3): 102286 [PMID: 40177210 DOI: 10.4254/wjh.v17.i3.102286] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i3/102286.htm |
| Number | Citing Articles |
| 1 |
Sayaka Kawai, Hiroshi Okada, Hideto Okamoto, Ren Yashiki, Megumi Minamida, Natsuko Shinagawa, Takahiro Ichikawa, Shinta Yamamoto, Noriyuki Kitagawa, Yoshitaka Hashimoto, Ryoichi Sasano, Kunimasa Yagi, Masahide Hamaguchi, Michiaki Fukui. Dihomo-γ-Linolenic Acid Elevation with Desaturase Imbalance in Metabolic Dysfunction-Associated Steatotic Liver Disease in a Japanese Health Checkups Cohort: HOZUGAWA Study, a Multi-Omic, Diet Adjusted Analysis. Nutrients 2025; 18(1): 57 doi: 10.3390/nu18010057
|
| 2 |
Li-Zhan Bie, Chao Wu, Jia-Lu Wang. Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study. World Journal of Hepatology 2025; 17(6): 107931 doi: 10.4254/wjh.v17.i6.107931
|
